share_log

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga ·  May 20 16:31

Gainers

  • Larimar Therapeutics (NASDAQ:LRMR) stock increased by 23.6% to $8.99 during Monday's after-market session. The company's market cap stands at $573.5 million.
  • GT Biopharma (NASDAQ:GTBP) stock rose 6.53% to $8.31. The company's market cap stands at $11.4 million. As per the press release, Q1 earnings came out 3 days ago.
  • DermTech (NASDAQ:DMTK) shares moved upwards by 5.52% to $0.38. The market value of their outstanding shares is at $13.2 million. As per the news, the Q1 earnings report came out 4 days ago.
  • BiomX (AMEX:PHGE) shares rose 5.38% to $0.36. The company's market cap stands at $19.8 million.
  • Sharecare (NASDAQ:SHCR) shares rose 4.99% to $0.88. The market value of their outstanding shares is at $317.7 million.
  • Inotiv (NASDAQ:NOTV) stock moved upwards by 4.89% to $1.93. The market value of their outstanding shares is at $49.7 million. As per the press release, Q2 earnings came out 3 days ago.

Losers

  • NovaBay Pharmaceuticals (AMEX:NBY) shares fell 9.9% to $0.16 during Monday's after-market session. The market value of their outstanding shares is at $5.9 million.
  • Sharps Technology (NASDAQ:STSS) stock declined by 7.26% to $0.23. The market value of their outstanding shares is at $3.6 million. The company's, Q1 earnings came out 4 days ago.
  • Scorpius Holdings (AMEX:SCPX) shares decreased by 5.88% to $0.15. The company's market cap stands at $5.4 million.
  • Cadrenal Therapeutics (NASDAQ:CVKD) stock declined by 5.53% to $0.41. The company's market cap stands at $6.5 million.
  • Turnstone Biologics (NASDAQ:TSBX) stock declined by 4.76% to $2.73. The company's market cap stands at $63.2 million.
  • Jin Medical International (NASDAQ:ZJYL) stock fell 4.64% to $2.92. The company's market cap stands at $456.8 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment